NCT00672633View on ClinicalTrials.gov

Trial of Lovaza in Adolescents With Mild to Moderately Elevated Triglycerides

PHASE2TerminatedINTERVENTIONAL

Enrollment

25

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

December 31, 2011

Study Completion Date

March 31, 2012

Conditions

Hypertriglyceridemia

Interventions

DRUG

Lovaza

Lovaza , 4 grams/day orally for 6 months

DRUG

Placebo

Corn Oil Pill, 4 pills/day orally for 6 months

Trial Locations (1)

02115

Children's Hospital Boston, Boston

Sponsors

Collaborators (1)

GlaxoSmithKline

All Listed Sponsors

collaborator

GlaxoSmithKline

INDUSTRY

lead

Boston Children's Hospital

OTHER

NCT00672633 - Trial of Lovaza in Adolescents With Mild to Moderately Elevated Triglycerides | Biotech Hunter | Biotech Hunter